vers la météo de la validation par utilisateur

Ingenuity303

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 48 - PMID ?

In soleus muscle from fasted __SP__ , 5 aminoimidazole 4 carboxamide riboside decreases ( by 40 percent ) activation of __SP__ __NODE__ beta protein .


Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante


Commentaires :
Analyse 0 
              +-------------------------------------------------COMP:V-N(In)------------------------------------------------+                          
              |                                         +------------------------------SUBJ:V-N-----------------------------+                          
              |                                         |                          +-----------OBJ:V-N----------+           +-------OBJ:V-N------+     
              +----------COMP:N-N(from)---------+       +----------OBJ:V-N---------+--COMP:V-N(by)--+           |           |       +MOD_ATT:N-AD+     
       +MOD_AT+                  +-MOD_ATT:N-ADJ+       |      +MOD_ATT:N-+SUBJ:V-N+           +MOD_+           +MOD_PO+    |       |      +MOD_A+     
       |      |                  |              |       |      |          |        |           |    |           |      |    |       |      |     |     
 In soleus muscle from fasted __SP__ , 5 aminoimidazole 4 carboxamide riboside decreases ( by 40 percent ) activation of __SP__ __NODE__ beta protein .
MOD_ATT:N-N (muscle,soleus)
COMP:N-N(from) (muscle,aminoimidazole)
MOD_ATT:N-ADJ (aminoimidazole,__SP__)
MOD_ATT:N-N (riboside,carboxamide)
OBJ:V-N (decrease,4)
SUBJ:V-N (decrease,riboside)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,activation)
MOD_ATT:N-ADJ (percent,@card@)
MOD_POST:N-ADJ (activation,of)
COMP:V-N(In) (__SP__,muscle)
SUBJ:V-N (__SP__,4)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,beta)
Analyse 1 
              +-------------------------------------------------COMP:V-N(In)------------------------------------------------+                          
              |                                 +-------------------------------COMP:V-N(from)------------------------------+                          
              |                                 |       +------------------------------SUBJ:V-N-----------------------------+                          
              |                                 |       |                          +-----------OBJ:V-N----------+           +-------OBJ:V-N------+     
              |                                 |       +----------OBJ:V-N---------+--COMP:V-N(by)--+           |           |       +MOD_ATT:N-AD+     
       +MOD_AT+                  +-MOD_ATT:N-ADJ+       |      +MOD_ATT:N-+SUBJ:V-N+           +MOD_+           +MOD_PO+    |       |      +MOD_A+     
       |      |                  |              |       |      |          |        |           |    |           |      |    |       |      |     |     
 In soleus muscle from fasted __SP__ , 5 aminoimidazole 4 carboxamide riboside decreases ( by 40 percent ) activation of __SP__ __NODE__ beta protein .
MOD_ATT:N-N (muscle,soleus)
MOD_ATT:N-ADJ (aminoimidazole,__SP__)
MOD_ATT:N-N (riboside,carboxamide)
OBJ:V-N (decrease,4)
SUBJ:V-N (decrease,riboside)
COMP:V-N(by) (decrease,percent)
OBJ:V-N (decrease,activation)
MOD_ATT:N-ADJ (percent,@card@)
MOD_POST:N-ADJ (activation,of)
COMP:V-N(In) (__SP__,muscle)
COMP:V-N(from) (__SP__,aminoimidazole)
SUBJ:V-N (__SP__,4)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,beta)